Shanghai Pharmaceuticals Holding Co. Ltd
Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic a… Read more
Shanghai Pharmaceuticals Holding Co. Ltd (SHPMF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: 0.031x
Based on the latest financial reports, Shanghai Pharmaceuticals Holding Co. Ltd (SHPMF) has a cash flow conversion efficiency ratio of 0.031x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.54 Billion) by net assets ($83.16 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shanghai Pharmaceuticals Holding Co. Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Shanghai Pharmaceuticals Holding Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shanghai Pharmaceuticals Holding Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Pharmaceuticals Holding Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bestechnic (Shanghai) Co. Ltd. A
SHG:688608
|
0.042x |
|
STRIDE INC. DL -0001
F:0AJ
|
N/A |
|
MAG Silver Corp
NYSE MKT:MAG
|
-0.006x |
|
Derwent London PLC
PINK:DWVYF
|
0.006x |
|
Bel Fuse B Inc
NASDAQ:BELFB
|
0.057x |
|
Alliance Resource Partners LP
NASDAQ:ARLP
|
0.077x |
|
RED ROCK RESORTS A DL-01
F:RRK
|
N/A |
|
Mineral Resources Limited
PINK:MALRF
|
0.209x |
Annual Cash Flow Conversion Efficiency for Shanghai Pharmaceuticals Holding Co. Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Pharmaceuticals Holding Co. Ltd from 1998 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $83.74 Billion | $5.83 Billion | 0.070x | +6.84% |
| 2023-12-31 | $80.33 Billion | $5.23 Billion | 0.065x | +7.10% |
| 2022-12-31 | $78.00 Billion | $4.74 Billion | 0.061x | -29.03% |
| 2021-12-31 | $59.07 Billion | $5.06 Billion | 0.086x | -31.47% |
| 2020-12-31 | $54.74 Billion | $6.84 Billion | 0.125x | +2.54% |
| 2019-12-31 | $49.39 Billion | $6.02 Billion | 0.122x | +80.61% |
| 2018-12-31 | $46.43 Billion | $3.14 Billion | 0.068x | +1.13% |
| 2017-12-31 | $39.68 Billion | $2.65 Billion | 0.067x | +26.32% |
| 2016-12-31 | $36.83 Billion | $1.95 Billion | 0.053x | +32.43% |
| 2015-12-31 | $33.81 Billion | $1.35 Billion | 0.040x | -7.08% |
| 2014-12-31 | $31.10 Billion | $1.34 Billion | 0.043x | +27.95% |
| 2013-12-31 | $29.00 Billion | $973.45 Million | 0.034x | -19.20% |
| 2012-12-31 | $27.70 Billion | $1.15 Billion | 0.042x | -39.10% |
| 2011-12-31 | $25.98 Billion | $1.77 Billion | 0.068x | -51.92% |
| 2010-12-31 | $11.88 Billion | $1.69 Billion | 0.142x | -50.39% |
| 2009-12-31 | $2.32 Billion | $664.13 Million | 0.286x | +109.19% |
| 2008-12-31 | $2.09 Billion | $285.68 Million | 0.137x | -45.25% |
| 2007-12-31 | $1.96 Billion | $488.94 Million | 0.250x | -11.50% |
| 2006-12-31 | $2.07 Billion | $583.11 Million | 0.282x | +675.17% |
| 2005-12-31 | $2.01 Billion | $73.00 Million | 0.036x | +21.65% |
| 2004-12-31 | $2.06 Billion | $61.66 Million | 0.030x | +13043.04% |
| 2003-12-31 | $2.13 Billion | $484.27K | 0.000x | -99.55% |
| 2002-12-31 | $2.00 Billion | $100.84 Million | 0.050x | +39.50% |
| 2001-12-31 | $1.82 Billion | $65.73 Million | 0.036x | -75.64% |
| 2000-12-31 | $985.30 Million | $146.22 Million | 0.148x | -23.41% |
| 1999-12-31 | $849.92 Million | $164.67 Million | 0.194x | +148.82% |
| 1998-12-31 | $713.42 Million | $-283.14 Million | -0.397x | -- |